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In the United States, breast cancer is the most common can-
cer among women except for skin cancer.1 The American 
Cancer Society estimates that in 2015, approximately 
231 840 new cases of invasive breast cancer will be diag-
nosed and that approximately 40 290 women will die from 
breast cancer.1 Major treatments for breast cancer, including 
surgery, chemotherapy, and radiation therapy, can cause 
significant physical distress that may persist for months or 
years after the completion of therapy.2 To this end, numer-
ous studies over the past 20 years have tested various strate-
gies to alleviate these complications, with many focusing 
on exercise. Many of these first-generation studies have 
shown that exercise training can mitigate many treatment-
related side effects and improve physical functioning and 
that regular exercise appears to be safe and well tolerated 
and is associated with few adverse events.3-5
Exercise is an attractive adjunct therapy for cancer patients 
and survivors because of its potentially positive influence on 
the immune system.6 One particular component of the 
immune system, the natural killer (NK) cell, is especially rel-
evant because of its ability to target and kill virally infected 
cells as well as cells that have undergone malignant 
transformation.7 In healthy athletic and nonathletic individuals, 
NK cells are extremely responsive to acute aerobic 
exercise. They follow a profile that typically shows marked 
elevations in both cell number and activity immediately 
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Abstract
Background. Current research examining the effect of exercise on immune responses in cancer survivors is limited. 
Objective. The aim of this pilot study was to examine the effect of 1 bout of intermittent exercise on natural killer (NK) 
cell numbers in breast cancer survivors. Methods. A total of 9 women with stage I to III invasive breast cancer who were 
3 to 6 months posttreatment and 9 sedentary women without a history of cancer completed 10 three-minute intervals 
of aerobic exercise on the cycle ergometer at 60% of VO2peak (peak oxygen uptake). Whole blood samples were taken 
pre-exercise, immediately postexercise, and at 2 hours and 24 hours postexercise. NK cell counts were assessed using 
flow cytometry. Results. In both groups, NK cell counts significantly increased immediately postexercise compared with 
pre-exercise (P = .004-.008) and returned to near pre-exercise levels during recovery (P = .129-.547). Absolute NK cell 
counts were significantly lower in breast cancer survivors immediately postexercise when compared with controls (P = 
.046). Conclusions. The breast cancer survivor group exhibited NK cell responses to 30 minutes of moderate-intensity 
intermittent aerobic exercise that were comparable with that in the group of physically similar women without a history 
of cancer. Immune changes related to cancer treatments may be related to the lower absolute NK cell counts observed in 
the breast cancer survivor group. Although the results of this study are preliminary in nature, they suggest that this type 
of exercise does not disrupt this aspect of innate immunity in recent breast cancer survivors, thereby supporting current 
exercise recommendations for this population.
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postexercise while displaying decreases during the recovery 
period for up to several hours.7-11 It is also thought that exer-
cise-related enhancements in NK cell function may confer a 
protective effect against pathogen invasion, whereas exercise-
related decreases in NK cell function may lead to increased 
incidence of viral infection and potential illness.9,10
Examining and understanding NK cell responses to 
acute aerobic exercise in breast cancer survivors is particu-
larly important when considering exercise prescription for 
this population. Currently, aerobic exercise prescriptions 
for cancer patients and survivors are largely modeled after 
those for the general population.12 Whereas much research 
has been conducted in healthy individuals, immune 
responses to exercise have not been systematically mea-
sured in breast cancer survivors. Because cancer treatments 
can lead to immune system deficiencies that may continue 
for extended periods of time posttreatment,13-15 one could 
hypothesize that a cancer patient’s weakened immune sys-
tem may not respond to exercise in the same way as that of 
a healthy individual. Typically, aerobic exercise prescrip-
tions are constructed of an accumulation of multiple acute 
exercise sessions per week. Therefore, exercise specialists 
and clinicians need to understand how long it takes for a 
breast cancer survivor’s immune system to recover from 1 
bout of aerobic exercise before prescribing the next bout of 
aerobic exercise. Current studies examining NK cell 
responses to exercise in breast cancer patients and survivors 
have shown promising results.13,16,17 However, these studies 
only examined resting NK cell function at the beginning 
and end of an exercise training period; none examined the 
acute exercise response, and none compared these responses 
with that of individuals who had never experienced the 
physiological toll of cancer treatments. Studying NK cell 
changes and function may provide insight into whether the 
exercise is contributing to enhanced immune function or 
leading to periods of potential immunosuppression. 
Therefore, the purpose of this investigation was to compare 
the effect of a single session of intermittent aerobic exercise 




Participants were recruited into a breast cancer survivor 
group and a control group. Participants in the breast cancer 
survivor group included women who had been diagnosed 
with stage I, II, or III invasive breast cancer; had received 
chemotherapy; and had completed all planned surgery, che-
motherapy, and radiation therapy 3 to 6 months prior to 
enrollment. They were recruited from the Medical Oncology 
and Radiation Oncology clinics at the North Carolina 
Cancer Hospital and from the waitlist for the Get REAL & 
HEEL Breast Cancer Rehabilitation Program in the 
Department of Exercise and Sport Science at the University 
of North Carolina at Chapel Hill (UNC-Chapel Hill). 
Participants in the control group included women who did 
not have a history of cancer diagnosis or treatment, were 
sedentary (ie, had not participated in regular organized 
physical activity within the past year), and were free from 
cardiovascular and musculoskeletal disease that would ren-
der aerobic exercise participation unsafe. They were 
recruited from the faculty, staff, and student populations at 
UNC-Chapel Hill as well as from across the surrounding 
geographic communities. All participants, regardless of 
study group, were between the ages of 40 and 70 years, 
were not regular users of anti-inflammatory medications, 
and had not experienced a menstrual period for approxi-
mately 1 year prior to enrollment (either as a result of being 
postmenopausal or as a result of cancer treatment). No par-
ticipant reported suffering from any other disease states or 
conditions. Approval from the Protocol Review Committee 
in the Lineberger Comprehensive Cancer Center, the 
Institutional Review Board in the Department of Exercise 
and Sport Science, and the Biomedical Institutional Review 
Board at UNC-Chapel Hill were obtained before proceed-
ing with participant recruitment. All participants were pro-
vided with hard copies of written informed consent 
documents. All participants, as well as the research team 
member obtaining consent for participation, signed all writ-
ten informed consent documents prior to performing any 
testing procedures.
Overview of Procedures
Each participant visited the laboratory on 3 separate occa-
sions. Prior to each laboratory visit, all participants were 
asked to refrain from eating for at least 2 hours prior to test-
ing, exercise and caffeine for at least 12 hours prior to test-
ing, alcohol use for at least 48 hours prior to testing and to 
maintain adequate hydration. Visit 1 included an orientation 
to the study, medical and physical screening, and the assess-
ment of peak aerobic capacity (peak oxygen uptake 
[VO
2peak
]) on the cycle ergometer. During visit 2, the par-
ticipants performed a moderate bout of intermittent aerobic 
exercise at 60% of VO
2peak
 for 30 minutes on the cycle 
ergometer. Blood samples were collected during this labo-
ratory visit, immediately prior to exercise, immediately 
postexercise, and 2 hours postexercise. Visit 3 occurred 24 
hours after the completion of exercise and consisted of only 
a follow-up resting blood draw. All laboratory visits 
occurred in the Integrative Exercise Oncology Research 
Laboratory and/or in the Applied Physiology Laboratory 
in the Department of Exercise and Sport Science at 
UNC-Chapel Hill.
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During the first visit to the laboratory, participants received 
an explanation of the study protocol, information regarding 
the potential risks of participation in the study and were 
asked to sign the informed consent documents. All partici-
pants completed a comprehensive medical history question-
naire and underwent a 12-lead resting electrocardiogram 
(ECG) and a physical exam by either a physician or other 
certified professional. Participants were screened for exclu-
sion based on the criteria put forth by the American College 
of Sports Medicine as contraindications to exercise 
testing.18
Age, race, height (portable stadiometer, Perspective 
Enterprises, Portage, MI), and body mass (calibrated bal-
ance-beam scale, Detecto, Webb City, MO) were recorded 
for all participants upon enrollment into the study. Height 
and body mass were used to calculate body mass index 
(BMI). Percentage body fat was assessed using a Discovery 
dual energy X-ray absorption scanner (Hologic, Inc, 
Bedford, MA). For participants in the breast cancer survi-
vor group, cancer treatment type was also recorded.
The final component of visit 1 was an exercise test to 
measure VO
2peak
. The purpose of measuring VO2peak was to 
assess peak aerobic capacity which would then be used to 
estimate the submaximal workload that participants would 
perform during laboratory visit 2. The VO
2peak
 test was per-
formed on an electronically braked cycle ergometer (Lode, 
Gronigen, Netherlands) using the Astrand Cycle Ergometer 
Maximal Test Protocol.19 Expired gases were collected and 
analyzed using a TrueMax 2400 Metabolic System (Parvo 
Medics, Salt Lake City, UT). Participants began the test sit-
ting quietly on the cycle ergometer for 3 minutes while rest-
ing metabolic data were collected. Participants then began 
the first stage of the test by cycling at 50 W for 3 minutes. 
At the end of the 3-minute stage, the workload was increased 
by 25 W every 3 minutes until volitional fatigue. Heart rate 
(HR), rating of perceived exertion (RPE),20 expired gases, 
and 12-lead ECG monitoring were performed throughout 
the test. HR and RPE were recorded at the end of every 
minute. The highest VO
2
 measured by the metabolic system 
during the last stage of the test was recorded at the partici-
pant’s VO
2peak
, and the corresponding workload on the cycle 
ergometer was recorded as the participant’s peak workload. 
Once the VO
2peak
 test was complete, the participant pedaled 
at a very low workload (<20 W), with ECG and blood pres-
sure monitoring continuing until they had returned to near-
baseline levels.21
VO2peak was calculated by the metabolic system, whereas 
the peak workload (W) was the workload at which the par-
ticipant was exercising when VO2peak was achieved. From 
these results, the workload (W) at 60% of VO
2peak
 was esti-
mated following the Karvonen procedures, by regressing 
VO
2
 values for each stage against the corresponding work-
load for that stage. This intensity was chosen because it is 
widely used in exercise prescriptions for this 
population.2,12,17,22-29
Visit 2: Acute Aerobic Exercise Session
During the second visit to the laboratory, participants per-
formed an acute bout of moderate aerobic exercise on the 
cycle ergometer at a workload corresponding to 60% of the 
participant’s VO2peak for 30 minutes. This combination of 
intensity and duration is commonly used in many studies 
that have examined the effects of aerobic exercise on physi-
cal functioning in breast cancer patients and is, therefore, 
representative of exercise prescriptions that are widely used 
for this population.3,12,17 However, previous pilot testing in 
the laboratory with recent breast cancer survivors demon-
strated that exercising on a cycle ergometer for 30 continu-
ous minutes at 60% of VO2peak was rather challenging. 
Therefore, to ensure that all participants would be able to 
complete the exercise session, an intermittent protocol was 
used, such that participants alternated 10 three-minute 
intervals of exercise with 90 s of rest, for a total of 30 min-
utes of exercise in a 43.5-minute period. All participants 
started the exercise session between 7:00 and 10:00 am to 
control for daily variations in the study variables.
At the beginning of visit 2, participants rested in the 
supine position for approximately 20 minutes while a cath-
eter was inserted into an antecubital vein in the arm for 
blood sampling. A 3-syringe technique was used for blood 
sampling. The first draw was a small amount to discard the 
contents of the catheter. The second draw contained the 
sample. The third injected a small amount of sterile saline to 
keep the catheter patent. A pre-exercise blood sample was 
drawn into K
3
EDTA Vacutainer tubes, which were used for 
the measurement of NK cell counts.
After the pre-exercise blood sample was obtained, par-
ticipants sat quietly on the cycle ergometer for 3 minutes 
while resting metabolic data were collected. After approxi-
mately 5 minutes of warm-up, participants began the 
30-minute moderate-intensity exercise bout at the pre-
scribed workload. HR and RPE were recorded at the end of 
every 3-minute period of exercise. Expired gases were 
monitored during the 1st, 3rd, 7th, and 10th exercise inter-
vals. If necessary, adjustments in workload were made to 
ensure that the participants were exercising as close to 60% 
of VO
2peak
 as possible for the entire 30 minutes. Immediately 
after completion of the exercise bout, participants dis-
mounted the cycle ergometer and returned to the supine 
position. Blood sampling immediately postexercise was 
performed in the same manner as described above.
Participants were then allowed to rest comfortably in the 
laboratory. They were allowed to drink water ad libitum; 
however, no food or other beverage could be ingested. A 
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final blood sample was obtained at 2 hours postexercise in 
the same manner as the other 2 samples. The catheter was 
then removed, and any necessary bandaging was 
performed.
Visit 3: 24-Hour Follow-up Session
The purpose of the third visit was to obtain a blood sample 
24 hours after the completion of the aerobic exercise bout. 
The blood sample was drawn from an antecubital vein using 
a standard venipuncture technique.
Determination of Immunological Parameters
Complete blood counts were obtained from all blood sam-
ples using a COULTER Ac•T diff Hematology Analyzer 
(Beckman Coulter, Inc, Brea, CA). Whole blood samples 
were stained using fluorescently labeled monoclonal anti-
bodies for the cell surface markers CD3, CD16, and CD56. 
The specific fluorescent labels were fluorescein isothyocya-
nate for the CD3 marker, phycoerythrin for the CD16 
marker, and allophycocyanin for the CD56 marker. 
Fluorescent staining was done to identify the proportion of 
lymphocytes that express the CD3-CD16+CD56+ phenotype 
that is characteristic of NK cells. Stained samples were fur-
ther prepared for flow cytometric analysis according to pro-
cedures adapted from protocols made available by Becton 
Dickinson.30 Samples were fixed in a 1% paraformaldehyde 
solution and analyzed within 24 hours of preparation using 
a CyAn 3 laser/9 color flow cytometer (Beckman Coulter, 
Inc). Flow cytometry data were viewed and analyzed using 
Summit 4.3 software (Dako North America, Inc, Carpinteria, 
CA). Absolute NK cell counts were calculated by multiply-
ing total lymphocyte counts by the NK cell proportions.
Calculation of Plasma Volume Shifts
Plasma volume shifts (changes in plasma volume caused by 
exercise) were calculated according to the equation given 
by Dill and Costill.31 The hematocrit and hemoglobin val-
ues that were used in these calculations were obtained from 
the complete blood count data pre-exercise immediately 
postexercise, 2 hours postexercise, and 24 hours postexer-
cise. Plasma volume shifts were reported to estimate the 
effect that exercise and posture had on fluid shifts, which 
may affect concentrations of leukocytes.
Statistical Analysis
Statistical analyses were performed using SAS version 9.3. 
All study variables were compared between groups using 
Wilcoxon rank sum tests and within groups using Wilcoxon 
signed rank tests, with significance set a priori at P < .05. In 
Tables 1 to 3 and in the text of the Results section, data are 
presented as mean ± standard deviation (SD). In Figure 1, data 
are displayed as boxplots to show the median and interquartile 
ranges of the NK cell counts. Although nonparametric statis-
tics were used for analysis, data are largely presented as 
mean ± SD to allow for easier comparison between the 




This study included a total of 18 participants, with 9 partici-
pants in the breast cancer survivor group and 9 participants 
in the control group. Physical characteristics for the 18 par-
ticipants are presented in Table 1. Age was the only physical 
characteristic for which there was a statistically significant 
difference between groups, where the average age of the 
control group was approximately 9 years more than that of 
the breast cancer survivor group (P = .013). Although the 
BMIs do not suggest obesity, the percentage of body fat 
(~42%) for both groups was very high. In addition, the 
VO
2peak
 results suggest very low aerobic fitness for both 
groups.
Table 1. Participant Physical Characteristics and VO
2peak.
a
Characteristic Breast Cancer Survivor Group (n = 9) Control Group (n = 9)
Age, years 50 ± 6b 59 ± 5b
Race, number of women Caucasian, 8; African American, 1 Caucasian, 9
Height, cm 164.7 ± 5.8 163.8 ± 5.9
Weight, kg 76.9 ± 12.6 77.7 ± 13.3
Body mass index, kg/m2 28.4 ± 5.0 28.9 ± 4.6
Percentage body fat (%) 41.6 ± 4.5 42.1 ± 4.0
VO
2peak
, mL/kg/min 18.1 ± 2.7 18.5 ± 5.1
Peak workload, W 107 ± 19 106 ± 17
Abbreviation: VO
2peak
, peak oxygen uptake.
aValues given are mean ± standard deviation.
bP < .05 for comparing age between groups.
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All participants in the breast cancer survivor group 
received surgery, chemotherapy, and radiation therapy and 
had completed these treatments within 3 to 6 months prior 
to enrollment. Four participants underwent mastectomy, 
and 5 underwent lumpectomy. A total of 6 participants 
received the chemotherapy combination of doxorubicin, 
cyclophosphamide, and paclitaxel, and one of these partici-
pants also received carboplatin; 1 participant received the 
chemotherapy combination of cyclophosphamide and 
docetaxel, and 2 participants received the chemotherapy 
combination of carboplatin and docetaxel; 6 participants 
were receiving adjuvant hormonal therapy, with 5 receiving 
tamoxifen and 1 receiving letrozole; and 2 participants were 
receiving adjuvant trastuzumab. Finally, 2 participants 
received additional medications related to their cancer treat-
ments, with one receiving lapatinib (an anti-HER 2 protein 
Table 2. Participant Heart Rate, Rating of Perceived Exertion, and Metabolic Responses During the Submaximal Aerobic Exercise 
Session.a
Parameter Breast Cancer Survivor Group Control Group
Submaximal VO
2
, mL/kg/min 12.1 ± 1.3 11.1 ± 2.1
Submaximal workload, W 59 ± 9 62 ± 11
Resting HR, beats/min 68 ± 6 66 ± 9
Exercise HR, beats/min 122 ± 18 119 ± 16
RPE 12 ± 1 12 ± 1
Abbreviations: VO
2
, oxygen uptake; HR, heart rate; RPE, rating of perceived exertion.
aValues given are mean ± standard deviation.
Table 3. Blood Cell Counts and Plasma Volume Shifts Across Time.a
Parameter Breast Cancer Survivor Group Control Group
Total leukocytes (cells/µL)
 Pre-exercise 3666.7 ± 1659.1 4377.8 ± 1072.1
 0h Postexercise 4964.7 ± 1973.4b 5540.1 ± 1089.4b
 2h Postexercise 5264.7 ± 1645.0c 5552.5 ± 1214.8c
 24h Postexercise 3642.6 ± 1370.8 4288.8 ± 1105.6
Total granulocytes (cells/µL)
 Pre-exercise 2633.3 ± 1320.0 2844.4 ± 610.6
 0h Postexercise 3608.3 ± 1445.9b 3570.5 ± 475.4b
 2h Postexercise 3986.3 ± 1285.0c 3610.7 ± 714.1c
 24h Postexercise 2560.1 ± 1068.4 2707.5 ± 744.5
Total monocytes (cells/µL)
 Pre-exercise 255.6 ± 133.3 400.0 ± 165.8
 0h Postexercise 370.0 ± 125.9b 449.1 ± 169.7
 2h Postexercise 308.6 ± 104.8 399.3 ± 181.3
 24h Postexercise 309.2 ± 133.1 364.8 ± 139.0
Total lymphocytes (cells/µL)
 Pre-exercise 788.9 ± 355.1 1111.1 ± 401.4
 0h Postexercise 987.0 ± 498.9d 1529.9 ± 513.6b,d
 2h Postexercise 945.8 ± 464.4c 1542.5 ± 654.2c
 24h Postexercise 761.5 ± 309.5e 1205.7 ± 358.8e
Plasma volume shifts (%)
 0h Postexercise −11.8 ± 3.8 −11.5 ± 4.6
 2h Postexercise −2.8 ± 6.3 −0.1 ± 9.2
 24h Postexercise −7.3 ± 6.7 −6.6 ± 7.1
Abbreviations: 0h, immediately postexercise; 2h, 2 hours postexercise; 24h, 24 hours postexercise.
aValues given are mean ± standard deviation.
bP < .05 for pre-exercise versus 0h postexercise.
cP < .05 for pre-exercise versus 2h postexercise.
dP < .05 for comparing 0h postexercise between groups.
eP < .05 for comparing 24h postexercise between groups.
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kinase inhibitor) and one receiving bevacizumab (an angio-
genesis inhibitor).
HR, RPE, and metabolic responses that the participants 
achieved during the moderate-intensity exercise session are 
presented in Table 2. Submaximal VO
2
 and workload were 
similar between groups (P = .267-.726). Additionally, pre-
exercise resting HR as well as exercise HR and RPE 
responses during the exercise session were similar between 
groups (P = .596-.757).
Leukocyte Subset Cell Counts and Plasma 
Volume Shifts
Cell counts for total leukocytes, granulocytes, monocytes, 
and lymphocytes as well as plasma volume shifts at each 
study time point are presented in Table 3. Total leukocyte, 
granulocyte, monocyte, and lymphocyte counts were 
adjusted to reflect the exercise-induced shifts in plasma vol-
ume. In the breast cancer survivor group, blood samples 
were not able to be obtained from 1 participant immediately 
postexercise (0h postexercise) and from 1 participant at 2 
hours postexercise because of difficulty in obtaining a blood 
sample through the angiocatheter. Exercise and recovery 
patterns of total leukocyte, leukocyte subsets, and plasma 
volume shifts were largely similar between breast cancer 
survivors and controls.
NK Cell Counts
Cell counts for NK cells are presented graphically as box-
and-whisker plots in Figure 1. In this figure, the line inside 
each box represents the median value, whereas the “x” 
inside each box represents the mean value. The upper and 
lower bounds of the box represent the interquartile range 
(IQR; ie, the middle 50% of the data). The upper and lower 
whiskers show the values that are within 1.5 × IQR of the 
75th and 25th percentiles, respectively, whereas the “x” 
above and below the whiskers denote outlier values. NK 
cell count at 24 hours postexercise was not able to be deter-
mined for 1 control participant because of difficulty obtain-
ing enough blood for sample preparation and analysis. 
When comparing groups, NK cell count was significantly 
lower immediately postexercise in the breast cancer survi-
vor group (172.8 ± 118.8 vs 286.8 ± 134.2 cells/µL, P = 
.046). Although statistically nonsignificant, NK cell counts 
were also consistently lower in the breast cancer survivor 
group pre-exercise (70.3 ± 37.9 vs 108.9 ± 51.7 cells/µL, 
P = .130), at 2 hours (93.0 ± 82.2 vs 131.3 ± 81.0 cells/µL, 
P = .285), and at 24 hours postexercise (90.9 ± 58.0 vs 
123.3 ± 62.4 cells/µL, P = .285).
Percentage changes for NK cell counts between study 
groups and across the 3 postexercise time points (relative to 
pre-exercise values) were also examined. Both groups dis-
played notably large percentage increases in NK cell counts 
immediately postexercise, relative to pre-exercise values 
(125.6% ± 75.6% and 184.4% ± 90.9% for the breast cancer 
survivor group and control group, respectively). At 2 and 24 
hours postexercise, the percentage change in NK cell counts 
indicated only slight differences compared with pre-exer-
cise levels in both groups (26.0% ± 51.3% and 24.2% ± 
61.1% at 2 hours postexercise and 32.6% ± 66.8% and 
14.8% ± 41.8% at 24 hours postexercise for the breast can-
cer survivor group and control group, respectively). 
Magnitudes of change in NK cell counts were similar 
between groups at each of the 3 postexercise time points 
(P = .182 to .813).
Discussion
This investigation is the first to examine the effect of acute 
aerobic exercise on any cellular immune parameter in breast 
cancer survivors. Absolute NK cell counts were consis-
tently lower in the breast cancer survivor group at each 
study time point compared with the control group, and this 
difference was most notable immediately postexercise. This 
study found that the magnitude of change for NK cell counts 
appears similar across time (0-24 hours postexercise) when 
comparing the breast cancer survivors and the controls, as 
evidenced by similar NK cell count percentage changes for 
both study groups.
Changes in NK Cell Counts
Absolute NK cell counts were consistently lower in the 
breast cancer survivor group across time compared with the 
control group—a finding that was statistically significant 
immediately postexercise. This result was not entirely 
Figure 1. Natural killer (NK) cell counts pre-exercise, 
immediately postexercise, and 2 and 24 hours postexercise in 
breast cancer survivors and controls.
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surprising, particularly after noting that total lymphocyte 
counts were also consistently lower in the breast cancer sur-
vivor group across time compared with the control group, a 
finding that was also significant immediately postexercise 
as well as 24 hours postexercise (see Table 3). Immune sys-
tem deficiencies such as lymphopenia can continue for 
extended periods of time posttreatment, and so the decreased 
total lymphocyte and NK cell counts observed in the breast 
cancer survivor group may have been related to the multi-
tude of treatments that they had recently experienced.13-15 
However, NK cell counts did significantly increase imme-
diately postexercise compared with pre-exercise levels in 
both groups, and then decreased toward pre-exercise levels 
at 2 hours and 24 hours postexercise. This is encouraging, 
suggesting that the breast cancer survivors seem to experi-
ence similar NK cell number recruitment compared with 
controls during and after 30 minutes of intermittent moder-
ate-intensity aerobic exercise. Additionally, the majority of 
the study participants did not experience below-baseline 
decreases in NK cell counts that are typically seen during 
the recovery period from exercise.7-11 Previous studies that 
have examined changes in NK cell counts in response to 
moderate-intensity and moderate-duration aerobic exercise 
in healthy men and women of various ages and fitness lev-
els have reported similar results.32-38 Additionally, Maisel 
et al39 examined the effect of an acute bout of treadmill 
exercise to exhaustion on circulating lymphocyte subpopu-
lations in congestive heart failure patients (another clinical 
population that often presents with low aerobic fitness) and 
matched healthy controls, finding that NK cell counts 
increased immediately postexercise in both groups, with 
magnitudes similar to those observed in the current study.
Several biological mechanisms may be associated with 
the rise and fall of NK cell counts during and after moder-
ate-intensity acute aerobic exercise. Increased cardiac out-
put during exercise may act synergistically with increased 
catecholamine levels to affect vascular endothelial lympho-
cyte adhesion, which would recruit NK cells from their 
marginal pools and other reservoirs.40-43 During the recov-
ery period, decreases in NK cell counts could be related to 
exercise-induced changes in catecholamines and cortisol, 
the latter of which may be mediated by changes in the 
inflammatory cytokine interleukin-6.43 The purpose of this 
current study did not involve direct exploration of potential 
biological mediators of the NK cell response to the moder-
ate-intensity acute aerobic exercise bout. However, separate 
analyses have been performed on participants’ stored blood 
samples, examining catecholamine and cortisol responses 
in response to the moderate-intensity exercise bout, the 
results of which are being considered elsewhere. In short, 
these analyses showed that although significant changes in 
plasma catecholamine and cortisol levels did occur in both 
study groups as a result of the moderate-intensity exercise 
bout, there were no significant correlations between changes 
in catecholamine or cortisol responses and changes in NK 
cell counts. This was likely a result of the small study sam-
ple size as well as the discontinuous nature of the exercise 
session, which may not have elicited enough of a catechol-
amine response to have an impact on β-adrenergic stimula-
tion of NK cells.
In the current investigation, it was interesting to note that 
even though absolute NK cell counts were lower in the 
breast cancer survivor group, the magnitude of change in 
NK cell counts was similar between groups. After observ-
ing these results, one question that arises is whether or not 
there were any differences in other markers of exercise 
intensity and perceived stress between the groups as 
reflected in the HR, RPE, and other metabolic responses. As 
shown in Table 2, no significant differences were observed 
between the breast cancer survivors and the controls for 
exercise HR responses, RPE responses, submaximal VO
2
, 
or submaximal workload during the moderate-intensity 
exercise session. Additionally, percentage exercise intensity 
based on HR reserve (53% ± 15% vs 56% ± 15%; P = .546) 
as well as percentage exercise intensity based on submaxi-
mal VO
2
 and VO2peak (68% ± 8% vs 64% ± 10%; P = .408) 
were also similar between the breast cancer survivors and 
controls. These similarities suggest that even though the 
cancer treatments may have affected the absolute immune 
cell counts of breast cancer survivors,6 the exercise bout 
resulted in an immune response, the magnitude of which 
paralleled that of controls who had never experienced can-
cer treatment.
In addition to examining the changes in NK cell counts 
themselves, another parameter that may be useful to inves-
tigate is changes in NK cell activity (NKCA) in response to 
exercise. The current study was able to explore changes in 
NKCA for 6 participants in the breast cancer survivor 
group, using a whole-blood flow cytometry assay adapted 
from Fondell et al.44 The NKCA results (measured as per-
centage target cell cytolysis in 500 mL of blood and 
expressed as mean ± SD) for the 6 participants in the breast 
cancer survivor group were 73.6% ± 30.3%, 74.4% ± 
21.0%, 67.6% ± 12.5%, and 60.2% ± 37.1% at pre-exercise, 
immediately postexercise, at 2 hours postexercise, and at 24 
hours postexercise, respectively. This exploratory analysis 
found that NKCA did not change significantly across the 
study time points for these 6 breast cancer survivors. This 
exploratory finding is interesting because one would expect 
that a measure of NK cell function would change in a man-
ner similar to that of NK cell counts. From a biological 
standpoint, the exact mechanisms are not clear. A similar 
result was observed by van der Pompe et al38 during and 
after graded exercise up to VO2max in postmenopausal 
women, in which the authors speculated that a component 
of the signaling pathways triggered by agonist stimulation 
of the β-adrenergic receptors on NK cells may be impaired 
in this population of participants.38 Other authors who have 
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observed relatively small changes in NKCA postexercise 
despite large changes in NK cell counts hypothesized that 
the NK cells that were recruited into circulation during 
exercise may have had decreased cytotoxic function com-
pared with the NK cells circulating pre-exercise.40 In the 
current study, the sharp increases in NK cell counts postex-
ercise accompanied by the relatively constant NKCA across 
time may likely be more related to the effects of increased 
cardiac output on NK cell cytosis rather than β-adrenergic 
stimulation, especially considering that the exercise bout 
was discontinuous and of moderate intensity and duration. 
However, no definite conclusions can be drawn from this 
exploratory analysis without data from more breast cancer 
survivors as well as from healthy controls for comparison. 
Furthermore, additional investigation of NKCA in breast 
cancer survivors using other assay techniques may be war-
ranted to allow a more comprehensive picture of NK cell 
function in this population.
Strengths, Limitations, and Recommendations 
for Future Research
As with any study, there are inherent strengths and limita-
tions. The study sample was very homogeneous and 
included a comparative control group of women. With the 
exception of age, the 2 study groups were matched very 
closely with regard to the other physical characteristics and 
aerobic fitness. Additionally, this study is one of the few to 
describe immune responses to acute aerobic exercise in the 
oncology patient population and is the only study to inves-
tigate the effect of acute aerobic exercise on NK cells in 
breast cancer survivors. Furthermore, it is one of the few 
studies to also include NK cell responses to acute aerobic 
exercise in healthy postmenopausal women as well as in a 
study sample with a low VO2peak (<20 mL/kg/min). 
However, this study was limited by its small sample size. 
Additionally, NK cell count data were not available for 2 
cancer survivors (one immediately postexercise and one 2 
hours postexercise) and 1 control at 24 hours postexercise 
because of difficulties obtaining blood samples from those 
participants at those times. Finally, a comprehensive picture 
of the effect of the exercise bout on NK cell function 
(NKCA) as well as all potential biological mediators of the 
NK cell response was not explored in this study. Therefore, 
biological mechanisms driving these results are largely 
speculative, especially when concerning results pertaining 
to the breast cancer survivor group.
As mentioned previously, immune responses to exercise 
have not been systematically measured in breast cancer survi-
vors. In addition to further examining NK cell responses to 
acute exercise in cancer patients and survivors, future studies 
should examine other cellular immune parameters that are 
also known to be responsive to acute aerobic exercise (eg, 
neutrophils, monocytes, T lymphocytes, and B lymphocytes). 
Future studies should also examine the effect of acute aero-
bic exercise on mediators of the immune response (ie, hor-
mones, cytokines, and prostaglandins) as well as investigate 
the effect of short “microcycles” of aerobic exercise on 
immune markers in cancer patients and survivors. Because 
exercise oncology research is ultimately used to construct 
exercise prescription guidelines for cancer patients and sur-
vivors, exercise specialists and clinicians must strive to 
understand how exercise affects all physiological systems, 
including the immune system. Thus, the most relevant and 
specific exercise guidelines can be created, so that cancer 
patients and survivors can reap the maximum health bene-
fits of exercise.
Conclusions
It was found that 30 minutes of intermittent, moderate-
intensity aerobic exercise elicited changes in NK cell counts 
in recent breast cancer survivors that were similar to those 
in physically similar women without a history of cancer 
diagnosis or treatment. Absolute NK cell counts were con-
sistently lower in the breast cancer survivor group com-
pared with the control group, particularly immediately 
postexercise, a finding that may be related to immune 
changes stemming from recent cancer treatments. 
Percentage changes in NK cell count were similar across 
time in both groups, implying that exercise affected the 
magnitude of NK cell response similarly in breast cancer 
survivors and controls. These findings suggest that intermit-
tent aerobic exercise of moderate intensity and duration 
does not disrupt this aspect of exercise-induced innate 
immune response in recent breast cancer survivors. 
Although more research investigating the effect of acute 
aerobic exercise on the immune system in cancer patients is 
warranted, this work supports current exercise recommen-
dations for cancer patients and survivors.
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